DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to Strong Sell Rating by Zacks Research

Zacks Research lowered shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a strong sell rating in a research note published on Monday,Zacks.com reports.

XRAY has been the topic of several other reports. Barrington Research reduced their price objective on DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating on the stock in a research note on Monday. Evercore ISI cut their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a research note on Thursday, November 6th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Finally, Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Two investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $16.08.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $10.99 on Monday. The stock has a market cap of $2.19 billion, a P/E ratio of -2.32, a PEG ratio of 0.81 and a beta of 1.00. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company has a 50-day moving average price of $12.86 and a 200 day moving average price of $14.45. DENTSPLY SIRONA has a 12-month low of $10.69 and a 12-month high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of large investors have recently modified their holdings of the business. AQR Capital Management LLC increased its holdings in DENTSPLY SIRONA by 109.8% in the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after buying an additional 6,970,086 shares in the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at about $39,700,000. Goldman Sachs Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after buying an additional 2,172,343 shares during the period. Brickwood Asset Management LLP lifted its stake in shares of DENTSPLY SIRONA by 5,515.8% during the 3rd quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock worth $19,340,000 after purchasing an additional 1,496,935 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after buying an additional 1,412,517 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.